
King Faisal Specialist Hospital and Research Centre (KFSHRC) says it completed the world’s first robotic-assisted implantation of an artificial heart pump. The hospital says this marks a significant advancement in medical technology and patient care.
Abbott designed its HeartMate 3 left ventricular assist device (LVAD) to help the heart pump blood when it fails to pump blood effectively on its own. The devices work by mimicking the pumping function of the heart’s left ventricle. The devices divert blood from the weakened left ventricle and propel it into the body’s main artery to help circulate blood throughout the body.
Abbott previously shared research demonstrating that HeartMate 3 can extend the lives of advanced heart patients by at least five years.
Dr. Feras Khaliel, head of cardiac surgery at KFSHRC, led the procedure. Khaliel also serves as director of the hospital’s Robotics and Minimally Invasive Surgery Program. A 35-year-old man hospitalized for 120 days due to advanced heart failure underwent the procedure. The patient’s heat failure also led to kidney and lung function deterioration. According to a news release, the patient is now on track to return home.
Following the procedure, the patient spent four days in the intensive care unit. The hospital says that compares to a 26-day average for similar procedures performed through traditional methods. Additionally, the hospital expects significantly reduced recovery time, with discharge expected within 10 days instead of the “usual” 63 days.
“We are honored to have partnered with KFSHRC in Saudi Arabia on this transformative initiative, with underscores the pivotal role of health technology in improving lives and enhancing health outcomes”, said Keith Boettiger, VP for Abbott’s heart failure business. “This achievement aligns with Abbott’s commitment to empowering people to live healthier, fuller lives.”